These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 17587214)

  • 21. Prenatal testing for aneuploidy in New Zealand: time for action.
    Stone P
    N Z Med J; 2005 Jun; 118(1217):U1545. PubMed ID: 15980916
    [No Abstract]   [Full Text] [Related]  

  • 22. Natural history of trisomy 21 fetuses with increased nuchal translucency thickness.
    Pandya PP; Snijders RJ; Johnson S; Nicolaides KH
    Ultrasound Obstet Gynecol; 1995 Jun; 5(6):381-3. PubMed ID: 7552798
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nuchal translucency-based Down syndrome screening: barriers to implementation.
    Malone FD
    Semin Perinatol; 2005 Aug; 29(4):272-6. PubMed ID: 16104681
    [TBL] [Abstract][Full Text] [Related]  

  • 24. First-trimester fetal nuchal translucency thickness and risk for trisomies.
    Pandya PP; Brizot ML; Kuhn P; Snijders RJ; Nicolaides KH
    Obstet Gynecol; 1994 Sep; 84(3):420-3. PubMed ID: 8058241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. First-trimester nuchal translucency: a risk analysis on fetal chromosome abnormality.
    van Vugt JM; van Zalen-Sprock RM; Kostense PJ
    Radiology; 1996 Aug; 200(2):537-40. PubMed ID: 8685353
    [TBL] [Abstract][Full Text] [Related]  

  • 26. First-trimester screening for fetal aneuploidy: biochemistry and nuchal translucency.
    Orlandi F; Damiani G; Hallahan TW; Krantz DA; Macri JN
    Ultrasound Obstet Gynecol; 1997 Dec; 10(6):381-6. PubMed ID: 9476320
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fetal echocardiography at the time of the nuchal translucency scan.
    Lombardi CM; Bellotti M; Fesslova V; Cappellini A
    Ultrasound Obstet Gynecol; 2007 Mar; 29(3):249-57. PubMed ID: 17318942
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening for aneuploidy in first and second trimesters: is there an optimal paradigm?
    Breathnach FM; Malone FD
    Curr Opin Obstet Gynecol; 2007 Apr; 19(2):176-82. PubMed ID: 17353686
    [TBL] [Abstract][Full Text] [Related]  

  • 29. First and second trimester evaluation of risk for fetal aneuploidy: the secondary outcomes of the FASTER Trial.
    D'Alton M; Cleary-Goldman J
    Semin Perinatol; 2005 Aug; 29(4):240-6. PubMed ID: 16104675
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Del (18p) syndrome with increased nuchal translucency revealed in prenatal diagnosis.
    Yakut S; Simsek M; Pestereli HE; Baumer A; Luleci G; Schinzel A
    Genet Couns; 2011; 22(3):317-9. PubMed ID: 22029175
    [No Abstract]   [Full Text] [Related]  

  • 31. Nuchal translucency measurement plus non-invasive prenatal testing to screen for aneuploidy in a community-based average-risk population.
    Jackson J; Hamar B; Lazar E; Lim K; Rodriguez D; Stock K; Wolfberg AJ; Dunk R
    Ultrasound Obstet Gynecol; 2014 Oct; 44(4):491. PubMed ID: 24890031
    [No Abstract]   [Full Text] [Related]  

  • 32. Nuchal translucency measurement and congenital heart defects: modest association in low-risk pregnancies.
    Müller MA; Clur SA; Timmerman E; Bilardo CM
    Prenat Diagn; 2007 Feb; 27(2):164-9. PubMed ID: 17238215
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Outcome of fetuses with malformations discovered before 14 weeks. Where the discovery is revealed by echography during the first trimester, is it responsible for the voluntary termination of the pregnancy? Comparison before and after July 2001].
    Mangione R; Fries N; Godard P; Fontanges M; Haddad G; Mirlesse V;
    J Gynecol Obstet Biol Reprod (Paris); 2008 Apr; 37(2):154-62. PubMed ID: 18036748
    [TBL] [Abstract][Full Text] [Related]  

  • 34. First trimester contingent testing with either nuchal translucency or cell-free DNA. Cost efficiency and the role of ultrasound dating.
    Conner P; Gustafsson S; Kublickas M
    Acta Obstet Gynecol Scand; 2015 Apr; 94(4):368-75. PubMed ID: 25581307
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcome of pregnancy in chromosomally normal fetuses with increased nuchal translucency in the first trimester.
    Souka AP; Krampl E; Bakalis S; Heath V; Nicolaides KH
    Ultrasound Obstet Gynecol; 2001 Jul; 18(1):9-17. PubMed ID: 11489218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased nuchal translucency as a marker for fetal chromosomal defects.
    Taipale P; Hiilesmaa V; Salonen R; Ylöstalo P
    N Engl J Med; 1997 Dec; 337(23):1654-8. PubMed ID: 9385124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcome of fetal exomphalos diagnosed at 11-14 weeks of gestation.
    Khalil A; Arnaoutoglou C; Pacilli M; Szabo A; David AL; Pandya P
    Ultrasound Obstet Gynecol; 2012 Apr; 39(4):401-6. PubMed ID: 21793081
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Increased fetal nuchal translucency as a predictor of Cantrell's pentology--case report].
    Staboulidou I; Wüstemann M; Schmidt P; Günter HH; Scharf A
    Z Geburtshilfe Neonatol; 2005 Dec; 209(6):231-4. PubMed ID: 16395641
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Down syndrome screening by ultrasound].
    Rozenberg P
    Gynecol Obstet Fertil; 2005; 33(7-8):526-32. PubMed ID: 16005667
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The implementation of first-trimester scanning at 10-13 weeks' gestation and the measurement of fetal nuchal translucency thickness in two maternity units.
    Pandya PP; Goldberg H; Walton B; Riddle A; Shelley S; Snijders RJ; Nicolaides KH
    Ultrasound Obstet Gynecol; 1995 Jan; 5(1):20-5. PubMed ID: 7850584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.